Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.45 USD | +27.29% |
|
-.--% | -.--% |
May. 10 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
May. 09 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- Low profitability weakens the company.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 1362.69 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Most analysts recommend that the stock should be sold or reduced.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 52.55B | - | ||
+1.59% | 102B | A- | ||
-6.47% | 62.47B | A- | ||
+6.44% | 35.34B | B | ||
+2.82% | 31.83B | A- | ||
+6.73% | 19.21B | B- | ||
+18.21% | 17.58B | C+ | ||
+8.81% | 13.89B | B- | ||
+75.12% | 12.76B | B- | ||
-7.05% | 12.68B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TPIA Stock
- PTCAY Stock
- Ratings PT Chandra Asri Pacific Tbk